The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology
Chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) share molecular mechanisms that cause the pathological symptoms they have in common. Here, we review evidence suggesting that hyperactivity of the EGFR/ADAM17 axis plays a role in the development of chronic lung disease in both CF...
Saved in:
Main Authors: | Marta Stolarczyk (Author), Bob J. Scholte (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analyze and Identify Peiminine Target EGFR Improve Lung Function and Alleviate Pulmonary Fibrosis to Prevent Exacerbation of Chronic Obstructive Pulmonary Disease by Phosphoproteomics Analysis
by: Xiaoyao Ma, et al.
Published: (2019) -
ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation
by: Jing Cheng, et al.
Published: (2022) -
Body composition and pulmonary function in Cystic Fibrosis
by: Saba eSheikh, et al.
Published: (2014) -
The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
by: Yunyun Quan, et al.
Published: (2022) -
Cystic Fibrosis Lung Disease in the Aging Population
by: Lisa Künzi, et al.
Published: (2021)